The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Iruxol Mono 1.2U/g Ointment

Smith & Nephew GmbHPA22696/001/001

Main Information

Trade NameIruxol Mono 1.2U/g Ointment
Active SubstancesProtease
Clostridiopeptidase a
Dosage FormOintment
Licence HolderSmith & Nephew GmbH
Licence NumberPA22696/001/001

Group Information

ATC CodeD03BA Proteolytic enzymes
D03BA52 collagenase, combinations


License statusAuthorised
Licence Issued03/09/1990
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceStore below 25°C.
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back